Pluristem Receives Patent In Singapore For 3D Cell Expansion Technology

(RTTNews) - Pluristem Therapeutics Inc. (PSTI) announced it has received a patent in Singapore titled "Methods for Cell Expansion and Uses of Cells and Conditioned Media Produced Thereby for Therapy."

Pluristem said patent No. 170761 is its second granted patent in Singapore, and relates to methods of expanding adherent stromal cells from human placental or adipose tissue using Pluristem's three-dimensional technology. Patents from the same family have previously been granted in Australia, India, Russia, and South Africa.

Pluristem said its intellectual property portfolio now includes 33 patents issued and approximately 120 more pending worldwide.